Stay updated on Pembrolizumab Combo in ES-SCLC 2nd-line Therapy Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in ES-SCLC 2nd-line Therapy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in ES-SCLC 2nd-line Therapy Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Updated the study's Locations section to add new site locations across the United States and internationally, while removing several previously listed sites. This changes where participants can enroll and access the trial.
    Difference
    2%
    Check dated 2025-12-24T15:10:07.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    35 days ago
    Change Detected
    Summary
    Added revision: v3.3.2 to the site footer. Removed revision: v3.2.0.
    Difference
    0.0%
    Check dated 2025-11-25T14:48:07.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    Added a Completed status dated 2025-11-12 and other related date updates; the 'Active, not recruiting' label was removed. The funding-lapse notice previously displayed has been deleted.
    Difference
    0.4%
    Check dated 2025-11-18T07:30:54.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    The 'Last Update Posted' label has been changed to 'Last Update Posted (Estimated)' to indicate the timestamp is an estimate. The previous plain label 'Last Update Posted' has been removed.
    Difference
    0.0%
    Check dated 2025-11-11T03:29:17.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    Study Details page now shows status 'Active, not recruiting' and a 'Last Update Posted' date; outdated 'Recruiting' text and contact details (e.g., Study Coordinator, phone) were removed.
    Difference
    0.3%
    Check dated 2025-11-03T21:41:23.000Z thumbnail image
  8. Check
    64 days ago
    Change Detected
    Summary
    Changed the Study Record Dates label from 'Last Update Posted' to 'Last Update Posted (Estimated)'; this is a minor formatting change that does not affect study content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-10-27T21:00:33.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in ES-SCLC 2nd-line Therapy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in ES-SCLC 2nd-line Therapy Clinical Trial page.